Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
777
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott